OUR TEAM Developing life-changing medicines requires a passionate team with deep industry expertise, diverse viewpoints, and innovative approaches. Paragon Leadership and Management Team JEFFREY S. ARONIN Chairman and CEO JAMES (JIM) ROBINSON President and COO TIMOTHY CUNNIFF EVP, Research & Development BRIAN FRIEDMAN CEO, Paragon Health Capital BABAR GHIAS EVP, Portfolio Management PATRICK MORRIS EVP, Legal Affairs and General Counsel ERIC MESSNER SVP, Business Development GREG ARONIN VP, External Affairs MATT FENSKE VP, Commercial MATTHEW GAINES VP, Strategic Capital SPIRO KATERINIS Chief Technology Officer STEPHEN WANASKI SVP, Research & Exploratory Development DARIEN PARHAD Chief Financial Officer JENNY SWALEC VP, Regulatory Affairs ARIS THEOLOGIS VP, Portfolio Management Paragon Advisory Board JEFF KINDLER SHLOMO YANAI SCOTT SEROTA H. MICHAEL COHEN PHIL GATTONE DESIREE LYON ANDREW PASTERNAK
